01—History
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $17.0M
YoY changeLargest recent move−50.0%in FY23Latest −59.5%
02—Ledger
03—Questions
What is Moderna, Inc.'s current proceeds from stock issuance?
Moderna, Inc. (MRNA) annual proceeds from stock issuance for 2025 was $17.0M, a 59.52% decline from 2024. Moderna, Inc. proceeds from stock issuance for the quarter ending December 31, 2021 was $0.
What was Moderna, Inc.'s proceeds from stock issuance in 2024?
Moderna, Inc. annual proceeds from stock issuance for 2024 was $42.0M, a 68.00% increase from 2023.
What was Moderna, Inc.'s proceeds from stock issuance in 2023?
Moderna, Inc. annual proceeds from stock issuance for 2023 was $25.0M, a 50.00% decline from 2022.
What is Moderna, Inc.'s 5-year proceeds from stock issuance CAGR?
Moderna, Inc. proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 60.87% from FY2020 to FY2025, going from $1.85B to $17.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)